Ail Divya A, Prakash Arjun, Damle Aditi, Karottue Swathi, Paulose Roopa R
Department of Pathology, Amrita Institute of Medical Sciences, Kochi, Kerala, India.
Department of Gastroenterology, Amrita Institute of Medical Sciences, Kochi, Kerala, India.
Indian J Pathol Microbiol. 2021 Apr-Jun;64(2):261-265. doi: 10.4103/IJPM.IJPM_870_19.
Kayexalate (Sodium Polystyrene Sulfonate/SPS) and K-bind (Calcium Polystyrene Sulfonate/CPS) are cation exchange resins, commonly used for treatment of hyperkalaemia. SPS/CPS induced injury of the gastrointestinal tract(GIT) is rare, can be potentially life threatening but is under-recognized. This study aims to increase awareness of pathologists and clinicians of this under-reported complication of a drug commonly used to treat hyperkalaemia.
Study population comprised patients with SPS/CPS (Kayexalate or its analogues) crystals identified in gastrointestinal specimens from 2017-2019 at a tertiary care centre. Clinical details, relevant investigations, imaging and endoscopic findings, patient follow up details were obtained from the hospital electronic information system.
A total of 10 patients with SPS/ CPS crystals in the GIT were encountered over 2 years. Male to female ratio was 9:1, with mean age 66.5years (range 52-82 years). Eight cases were mucosal biopsies and 2 were resection specimens. Additional pathology (tumours, colonic perforation) was present in 80% of patients. The characteristic morphological appearance of the CPS/SPS crystals on H&E stains were supported by special stains -Periodic acid Schiff(PAS) and Acid fast Bacilli(AFB). In all cases, the treatment history with SPS/CPS for hyperkalaemia was obtained only after the histological examination. Most common etiology of hyperkalaemia encountered was chronic kidney disease(CKD)/ Acute on chronic kidney disease.
It is important for pathologists to recognise the presence of these crystals especially in small biopsies as early feedback to clinicians can help in appropriate management and avoidance of more serious adverse outcome. To the best of our knowledge, this is the first series of 10 consecutive cases of SPS/CPS crystals encountered in gastrointestinal tract to be reported from India.
降钾树脂(聚苯乙烯磺酸钠/SPS)和钾结合剂(聚苯乙烯磺酸钙/CPS)是阳离子交换树脂,常用于治疗高钾血症。SPS/CPS引起的胃肠道(GIT)损伤较为罕见,可能危及生命,但却未得到充分认识。本研究旨在提高病理学家和临床医生对这种用于治疗高钾血症的常用药物未被充分报道的并发症的认识。
研究人群包括2017年至2019年在一家三级医疗中心的胃肠道标本中发现有SPS/CPS(降钾树脂或其类似物)晶体的患者。从医院电子信息系统中获取临床细节、相关检查、影像学和内镜检查结果以及患者随访细节。
在两年内共遇到10例胃肠道中有SPS/CPS晶体的患者。男女比例为9:1,平均年龄66.5岁(范围52 - 82岁)。8例为黏膜活检,2例为切除标本。80%的患者存在其他病理情况(肿瘤、结肠穿孔)。苏木精-伊红(H&E)染色显示的CPS/SPS晶体的特征性形态外观得到了特殊染色——过碘酸希夫(PAS)染色和抗酸杆菌(AFB)染色的支持。在所有病例中,仅在组织学检查后才了解到使用SPS/CPS治疗高钾血症的病史。所遇到的高钾血症最常见的病因是慢性肾脏病(CKD)/慢性肾脏病急性加重。
病理学家认识到这些晶体的存在非常重要,尤其是在小活检中,因为早期向临床医生反馈有助于进行适当的管理并避免更严重的不良后果。据我们所知,这是印度首次报道的连续10例胃肠道中遇到SPS/CPS晶体的病例系列。